毒素在治疗获得的非适应性伴随性食otropia的长期疗效
Min Seok Kang1, Jihae Park2, Hee Kyung Yang3
1Department of Ophthalmology, Kyung Hee University Hospital, Seoul, South Korea.
Scientific reports
|February 17, 2025
概括
毒素A (BTX) 注射对获得的非适应性伴随性食otropia (ANAET) 有效,在最终检查中显示高达73.8%的成功率. 建议BTX作为ANAET患者的第一线治疗,其基线偏差为15 PD或更低.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
背景情况:
- 获得的非适应性伴随性食热症 (ANAET) 影响着老年儿童和成年人.
- 毒素A (BTX) 用于治疗各种眼部疾病,包括.
研究的目的:
- 评估BTX注射在治疗ANAET的长期疗效.
- 确定影响ANAET患者治疗成功的因素.
主要方法:
- 对42名接受BTX治疗的ANAET患者 (2010-2022) 的回顾性审查.
- 收集的数据包括治疗前后的ES偏差角度,BTX剂量和并发症.
- 成功被定义为食的最终眼睛对齐 ≤ 6 PD.
主要成果:
- 治疗成功率高:六个月后90.5%,一年后76.2%,最终随访73.8% (平均23.7个月).
- 基线偏差角度 (≤15 PD) 是最终成功的唯一显著预测指标 (p=0.008).
结论:
- 注射BTX为ANAET提供了一个有利的治疗选择.
- 对于ANAET患者,BTX是最适合的第一线治疗,其最大偏差为15 PD或更小,以获得持续的成功.
相关概念视频
Angle Closure Glaucoma: Treatment
430
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
430
Open Angle Glaucoma: Treatment
384
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
384
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
650
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
650
Skeletal Muscle Relaxants: Therapeutic Uses
460
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
460
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
672
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
672


